2025 Hybrid US Bioassay Conference

9th Annual  |  Tucson, Arizona, USA  |  March 24-26, 2025

Marriott Tucson University Park Hotel

BEBPA conferences include 3 days of presentations, workshops and round-table discussions on topics of current interest to the analytical biopharmaceutical community. It is hoped that these presentations and discussions will provide topics for future white paper working groups.

Registration

Registration is open for our Hybrid 2025 US Bioassay Conference. In-person registration closes March 14, 2025 and virtual registration closes March 19, 2025.

Agenda

Our Hybrid 2025 US Bioassay Conference agenda is coming soon! Check the agenda for updates as we finalize our schedule.

2025 USB Speaker Abstracts

Submit your speaker abstract or poster online through our website until June 28, 2024.

Suggested Topics:

  • Regulatory perspective on the Cell and Gene Therapy Potency Guidance’s (2023 and 2011)
  • Academic talks about research in new technologies for example:
    • AI
    • Organ on a chip
  • Multiplex assays; development and validation
  • Flow cytometry
  • Absolute potency vs relative potency for gene therapy products
  • Phase appropriate validations
  • Critical reagent management
  • Bioassay optimization and validation status
  • Automation of (cell-based) potency assays from cell culture all the way to data processing
  • Best practices for Reference Material a year post guidance
  • Non-parallelism between test sample and reference standard
  • Transitioning from academic research to industry
  • Bridging done between continuous culture and FRTU in an established potency assay

Hotel Information

A room block is being prepared for the 2025 Hybrid US Bioassay Conference. Check back for updates!

Marriott Tucson University Park Hotel

880 East 2nd Street,
Tucson, Arizona, 85719

Telephone: 520-792-4100
Website: Marriott Tucson University Park Hotel